BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20962090)

  • 41. Impact of HVT Vaccination on Splenic miRNA Expression in Marek's Disease Virus Infections.
    Hicks JA; Liu HC
    Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30764490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Marek's disease virus-encoded microRNAs: genomics, expression and function.
    Luo J; Teng M; Fan J; Wang F; Zhou L; Deng R; Zhang G
    Sci China Life Sci; 2010 Oct; 53(10):1174-80. PubMed ID: 20953939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Latency and tumorigenesis in Marek's disease.
    Nair V
    Avian Dis; 2013 Jun; 57(2 Suppl):360-5. PubMed ID: 23901747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line.
    Lian L; Li X; Zhao C; Han B; Qu L; Song J; Liu C; Yang N
    Poult Sci; 2015 Nov; 94(11):2616-21. PubMed ID: 26500265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Marek's Disease Virus (
    Zhu ZJ; Teng M; Li HZ; Zheng LP; Liu JL; Chai SJ; Yao YX; Nair V; Zhang GP; Luo J
    Front Microbiol; 2020; 11():596422. PubMed ID: 33224130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct expression pattern of miRNAs in Marek's disease virus infected-chicken splenic tumors and non-tumorous spleen tissues.
    Li ZJ; Zhang YP; Li Y; Zheng HW; Zheng YS; Liu CJ
    Res Vet Sci; 2014 Aug; 97(1):156-61. PubMed ID: 24794245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of a novel Marek's disease virus type 1 (MDV1)-specific protein p40 in insect cells by a baculovirus vector and in chick embryo fibroblasts infected with MDV1.
    Urakawa T; Sakaguchi M; Yamamoto M; Zhu GS; Hirai K
    Arch Virol; 1994; 137(1-2):191-7. PubMed ID: 7979993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small RNA cloning and sequencing strategy affects host and viral microRNA expression signatures.
    Stik G; Muylkens B; Coupeau D; Laurent S; Dambrine G; Messmer M; Chane-Woon-Ming B; Pfeffer S; Rasschaert D
    J Biotechnol; 2014 Jul; 181():35-44. PubMed ID: 24746587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of microRNAs in two genetically disparate chicken lines showing different necrotic enteritis disease susceptibility.
    Dinh H; Hong YH; Lillehoj HS
    Vet Immunol Immunopathol; 2014 May; 159(1-2):74-82. PubMed ID: 24629767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparin inhibits plaque formation by cell-free Marek's disease viruses in vitro.
    Lee SI; Ohashi K; Sugimoto C; Onuma M
    J Vet Med Sci; 2001 Apr; 63(4):427-32. PubMed ID: 11346178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Putative roles as oncogene or tumour suppressor of the Mid-clustered microRNAs in Gallid alphaherpesvirus 2 (GaHV2) induced Marek's disease lymphomagenesis.
    Teng M; Yu ZH; Zhao P; Zhuang GQ; Wu ZX; Dang L; Li HZ; Ma SM; Cui ZZ; Zhang GP; Wu R; Luo J
    J Gen Virol; 2017 May; 98(5):1097-1112. PubMed ID: 28510513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of Marek's Disease Virus Oncoprotein Meq During Infection in the Natural Host.
    Tai SS; Hearn C; Umthong S; Agafitei O; Cheng HH; Dunn JR; Niikura M
    Virology; 2017 Mar; 503():103-113. PubMed ID: 28160668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular characterization and phylogenetic analysis of oncogenes from virulent serotype-1 Marek's disease virus in India.
    Prathibha Y; Sreedevi B; Kumar NV; Srilatha CH
    Acta Virol; 2018; 62(3):277-286. PubMed ID: 30160143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Marek's Disease Virus Requires Both Copies of the Inverted Repeat Regions for Efficient
    Vychodil T; Conradie AM; Trimpert J; Aswad A; Bertzbach LD; Kaufer BB
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33115875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unraveling the role of B cells in the pathogenesis of an oncogenic avian herpesvirus.
    Bertzbach LD; Laparidou M; Härtle S; Etches RJ; Kaspers B; Schusser B; Kaufer BB
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11603-11607. PubMed ID: 30337483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomics and Marek's disease virus.
    Burnside J; Morgan RW
    Cytogenet Genome Res; 2007; 117(1-4):376-87. PubMed ID: 17675881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA profiling in the bursae of Marek's disease virus-infected resistant and susceptible chicken lines.
    Heidari M; Zhang L; Zhang H
    Genomics; 2020 May; 112(3):2564-2571. PubMed ID: 32059995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.
    Sonoda K; Sakaguchi M; Okamura H; Yokogawa K; Tokunaga E; Tokiyoshi S; Kawaguchi Y; Hirai K
    J Virol; 2000 Apr; 74(7):3217-26. PubMed ID: 10708438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Down-regulation of MHC class I by the Marek's disease virus (MDV) UL49.5 gene product mildly affects virulence in a haplotype-specific fashion.
    Jarosinski KW; Hunt HD; Osterrieder N
    Virology; 2010 Sep; 405(2):457-63. PubMed ID: 20637486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging roles of chicken and viral microRNAs in avian disease.
    Burnside J; Morgan R
    BMC Proc; 2011 Jun; 5 Suppl 4(Suppl 4):S2. PubMed ID: 21645299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.